Shourong Wu

Key Laboratory Of Biorheological Science And Technology
Chongqing, 400044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis.

YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis.

Journal: Acta pharmacologica Sinica

Published: March 16, 2026

NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression.

NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression.

Journal: Oncogenesis

Published: May 26, 2025

Transcription Factor YY2 Inhibits Tumor Cell Glutamine Catabolism by Regulating GLS1 RNA Splicing Isoform GAC.

Transcription Factor YY2 Inhibits Tumor Cell Glutamine Catabolism by Regulating GLS1 RNA Splicing Isoform GAC.

Journal: The American journal of pathology

Published: October 26, 2024

p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.

p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.

Journal: Oncogene

Published: January 26, 2024

The two sides of chromosomal instability: drivers and brakes in cancer.

The two sides of chromosomal instability: drivers and brakes in cancer.

Journal: Signal transduction and targeted therapy

Published: September 27, 2023

The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway.

The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway.

Journal: Oncogenesis

Published: December 27, 2022

SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis.

SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis.

Journal: Acta pharmacologica Sinica

Published: June 21, 2022

Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma.

Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma.

Journal: Cellular and molecular life sciences : CMLS

Published: April 27, 2022

p52-ZER6: a determinant of tumor cell sensitivity to MDM2-p53 binding inhibitors.

p52-ZER6: a determinant of tumor cell sensitivity to MDM2-p53 binding inhibitors.

Journal: Acta pharmacologica Sinica

Published: March 29, 2022

Intramuscular injection of sotagliflozin promotes neovascularization in diabetic mice through enhancing skeletal muscle cells paracrine function.

Intramuscular injection of sotagliflozin promotes neovascularization in diabetic mice through enhancing skeletal muscle cells paracrine function.

Journal: Acta pharmacologica Sinica

Published: November 20, 2021

NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.

NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.

Journal: Oncogene

Published: May 01, 2021

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.

Journal: Acta pharmacologica Sinica

Published: September 04, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026